Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
Le Guen Y, Raulin AC, Logue MW, et al
Your BPC-157 protocol is prepared by our licensed 503A compounding pharmacy partner
Our team is here to help
NAD+ Therapy NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every cell of your body, and its essential for energy production, cellular repair, and healthy aging
These include: Tingling, numbness, or a 'pins and needles' sensation in the hands and feet Difficulty with balance and coordination Muscle weakness Memory problems, difficulty concentrating, or 'brain fog' Mood changes, including low mood or irritability Important: New or worsening neurological symptoms such as paraesthesia, gait disturbance, or cognitive change should be treated as urgent
